Rising costs, muted demand to weigh on FMCG margins in Q1
Live Events
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
ET Intelligence Group: Select companies in the fast moving consumer goods (FMCG) sector are expected to show marginal pickup in sales volume for the June quarter. Revenue growth will likely be driven by higher prices for some firms while others may report pressure due to weak demand. Margins may contract due to higher material costs and increased advertising spend for some companies. Marico and Tata Consumer Products are top picks of most analysts.The sector major, Hindustan Unilever 's volume growth is expected to revive to 3% for the June 2025 quarter given gradual recovery in demand. After clocking a 4% improvement in the year-ago quarter, volume growth fell in each of the following quarters to 2% in the March 2025 quarter. Operating profit may remain flat while margins are likely to contract by 1% due to rise in advertising and promotion costs to boost volumes.The cigarettes-to-paperboards maker, ITC is expected to sustain the year-on-year cigarette volume growth at the March quarter level of 5%. Paperboard growth is expected to remain weak due to sluggish export markets, weaker realisations and cheap Chinese supplies. Margins are expected to decline in both the categories due to surge in raw material costs. On the other hand, agri-business growth is expected to be in double-digit at around 10%. Nestle India is likely to deliver a 6% year-on-year growth in revenue, supported by about 6.5-7% rise in sales volume and price increase. However, inflation in coffee, cocoa, milk and edible oils could add pressure on the margin front. Varun Beverages (VBL), a major bottler of PepsiCo, may report flat revenue due to decline in volumes amid early onset of the monsoon season. According to Motilal Oswal Financial Services (MOFSL), the operating margin before depreciation and amortisation (Ebitda margin) may contract by 150 basis points. Britannia Industries is likely to clock volume growth of 3-4% while price increase implemented in the June 2025 quarter may drive revenue up by 9%. High agricultural commodity costs are likely to weigh on margins, though profit may rise by around 9% due to higher product prices.Revenue of Tata Consumer Products is expected to rise 11%, supported by growth in the domestic tea business. Salt segment is also expected to be driven by higher volumes and price increase. Marico's revenue may jump around 22% driven by 8-9% volume growth in the domestic market and higher product prices. On the contrary, margins are expected to contract by 330 bps points due to copra inflation and higher base.FMCG stocks outperformed the frontline indices in the past month where the Nifty FMCG index jumped 3.6% compared with around 1% rise in the benchmark Nifty 50 and BSE Sensex indices.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
14 minutes ago
- Time of India
Trump pauses export controls to bolster China trade deal: Report
The United States has temporarily eased restrictions on technology exports to China. This decision aims to facilitate ongoing trade negotiations with Beijing. It also supports President Trump's efforts to meet with President Xi Jinping. The Commerce Department has been instructed to avoid taking strict actions against China. Nvidia will resume sales of its H20 GPUs to China. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The U.S. has paused curbs on tech exports to China to avoid disrupting trade talks with Beijing and support President Donald Trump 's efforts to secure a meeting with President Xi Jinping this year, the Financial Times said on industry and security bureau of the Commerce Department, which oversees export controls, has been told in recent months to avoid tough moves on China, the newspaper said, citing current and former could not immediately verify the report. The White House and the department did not respond to Reuters' requests for comment outside business U.S. and Chinese economic officials are set to resume talks in Stockholm on Monday to tackle longstanding economic disputes at the centre of a trade war between the world's top two giant Nvidia said this month it would resume sales of its H20 graphics processing units (GPU) to China, reversing an export curb the Trump administration imposed in April to keep advanced AI chips out of Chinese hands over national security planned resumption was part of U.S. negotiations on rare earths and magnets, Commerce Secretary Howard Lutnick has paper said 20 security experts and former officials, including former deputy US national security adviser Matt Pottinger, will write on Monday to Lutnick to voice concern, however."This move represents a strategic misstep that endangers the United States' economic and military edge in artificial intelligence," they write in the letter, it added.
Mint
14 minutes ago
- Mint
Bull Case Forecast: Sensex may hit 1,15,836 and Nifty 43,876 by FY28, says Ventura
Indian equity market is likely to deliver strong gains over the next few years, with the benchmark indices potentially rising 42 percent by fiscal 2028, according to Ventura Securities. Despite a turbulent global economic backdrop, the brokerage sees India's strong GDP growth, manageable debt levels, and relatively stable bond yields as key drivers positioning the country ahead of global peers. In its latest forecast, Ventura Securities said that the Sensex could reach 1,15,836 and the Nifty 50 could climb to 43,876 by FY28 in a bullish scenario. These projections are supported by a compound annual earnings per share (EPS) growth rate of 12–14 percent and macroeconomic stability. Even in a more conservative or bearish environment, the brokerage sees solid upside. It estimates the Sensex could still rise to 104,804 points and the Nifty 50 to 39,697. The forecast is underpinned by a price-to-earnings (PE) multiple of 21 times in the bull case and 19 times in the bear case, with estimated FY28 EPS at 5,516 for the Sensex and 2,089 for the Nifty. According to Ventura, India's unique macroeconomic combination — relatively high growth, moderate debt, and benign interest rates — gives it an edge over advanced economies like the US and Japan. 'India's large growth market is likely to outpace its global peers supported by a unique combination of strong GDP growth, moderate debt levels, and comparatively benign bond yields,' the brokerage noted. Ventura's bullish outlook is also shaped by encouraging Q1FY26 earnings season trends. As of mid-quarter, 159 companies have declared their results, with broad-based growth across sectors. Engineering, manufacturing, and services led the charge, while consumption, commodities, and pharmaceuticals delivered steady performances. Sectors such as BFSI, IT, healthcare, and logistics have delivered positive earnings surprises. This, Ventura said, highlights the resilience of Indian corporate earnings and reinforces confidence in long-term fundamentals. 'India remains the world's most promising investment destination,' the brokerage added, citing GDP growth at 6.5 percent, a debt-to-GDP ratio around 80%, and stable bond yields. While developed markets face headwinds such as high debt and sluggish growth, India's demographic dividend and structural economic reforms continue to attract global capital. Vinit Bolinjkar, Head of Research at Ventura Securities, said the past decade has proven India's resilience despite multiple crises. 'In the last 10 years, the Indian economy has demonstrated resilience and clocked the highest GDP growth among large economies, despite global headwinds such as the NBFC crisis, COVID-19, Russia–Ukraine war, and the recent uncertainty on Trump tariffs,' he said. According to Bolinjkar, India's ability to mitigate risks will outweigh existing challenges and help push GDP growth to an estimated 7.3 percent by FY30. Strategic measures like the discovery of oil in the Andaman region, the gold monetization scheme, and a multi-pronged national security strategy are expected to add further strength to India's macroeconomic fundamentals. Ventura believes that the Indian equity market has not yet priced in the long-term structural advantages the country offers. Factors such as rising foreign exchange reserves, sustainable debt levels, and the possibility of lower interest rates could create a highly favorable investment landscape in the coming years. In this context, the Sensex's journey to 115,000 and beyond looks achievable — provided the current momentum in earnings and reforms continues. For investors looking beyond short-term volatility, India stands out as a resilient and rewarding long-term bet. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Laurus rallies 6%, hits new high on strong Q1; brokerages see more upside
Laurus Labs share price today Shares of Laurus Labs hit a new high of ₹889.3, surging 6 per cent on the BSE in Monday's intra-day trade in an otherwise subdued market after the company reported strong earnings for the June 2025 quarter (Q1FY26). The BSE Sensex was up 0.06 per cent at 81,512 at 10:20 AM. In the past one month, the stock of pharmaceutical company has outperformed the market by soaring 27 per cent, as compared to 2.7 per cent decline in the BSE Sensex. It has zoomed 128 per cent from its 52-week low of ₹390.30 on August 8, 2024. Laurus Labs - Q1FY26 performance, outlook Laurus delivered a solid performance in Q1, in line with market expectations. The management said they are pleased to see sustained growth momentum fueled by increasing uptake in the contract development and manufacturing organisation (CDMO) deliveries and healthy business fundamentals. The company has achieved revenues of ₹1,570 crore, representing 31 per cent year-on-year (YoY) growth and earnings before interest, taxes, depreciation, and amortization (EBITDA) of ₹389 crore, representing 127 per cent growth. The EBITDA margins improved substantially to 24.8 per cent, from 14.3 per cent in Q1FY25, supported by continuing operating leverage. Gross margins stood strong at 59.4 per cent due to favorable CDMO mix and ongoing process improvement initiatives. Profit after tax stood ₹161.1 crore, driven by a favorable product mix and strong operational performance. Laurus has made a healthy progress to start the year with increasing contributions from the CDMO business and continued advancement of pipeline projects, supported by Generic Formulation (FDF). The management said the company is moving ahead with strong focus on commercial execution realizing the full potential from promising pipeline opportunities, business development and rapidly enhancing scale and technology capabilities. ALSO READ | Brokerages firm see more upside in stock price of Laurus The CDMO growth was driven by several mid-to-late stage NCE deliveries and steady increase in sales from new manufacturing assets. Out of ₹3,200 core of capex that the company has incurred during FY22-25, almost ~75 per cent was earmarked towards active pharmaceutical ingredient (API) / CDMO. The company is now getting the benefit of the same as the CDMO quarterly run rate has gone up from ₹220-250 crore to ₹450-500 crore in two years. The CDMO contribution has also gone up from ~16 per cent to 33 per cent which has led to a significant margin expansion. ICICI Securities said they continue to monitor progress on these driving factors which in a way are expected to change the business mix in favour of these segments in lieu of anti-retroviral (ARV). Analysts at Choice Equity Broking believe Laurus is evolving from a traditional Generics player to a CDMO (Synthesis)–led model, with the segment targeted to reach ~50 per cent of revenues in the long term. Given the higher-margin profile of CDMO and operating leverage as new manufacturing assets ramp and current underutilization narrows, the brokerage firm expects sustained margin expansion. Analysts maintain 'buy' rating on the stock with revised target price of ₹1,025 against previous target price of ₹750. Motilal Oswal Financial Services raise earnings estimates by 16 per cent/7 per cent for FY26/FY27, factoring in strong tailwinds in CDMO segment led by 110+ active pipeline projects/ramp-up from new manufacturing facilities, additional contracts in generic FDF segment, and margin expansion from scale. Considering a 63 per cent earnings compounded annual growth rate (CAGR) over FY25-27, the brokerage firm value Laurus at 56x 12M forward earnings to arrive at a target price of ₹970. Reiterate BUY.
